Last reviewed · How we verify
NCT04474418: Be-PART
Psychometric Characterization of Patients With Cardiac Arrhythmias
trial in Cardiac Arrhythmia in 150 participants. Status unknown.
1 January 2021
Quick facts
| Lead sponsor | Charite University, Berlin, Germany |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 9 October 2018 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 August 2021 |
| Sites | 1 location across Germany |
Conditions studied
- Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
- Anxiety — all drugs for Anxiety →
- Personality — all drugs for Personality →
- Psychological Stress — all drugs for Psychological Stress →
Sponsor
Charite University, Berlin, Germany
Who can join
18 and older, any sex, with Cardiac Arrhythmia or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the influence of different psychological parameters (e.g. depression, anxiety, personality traits, resilience, tolerance of uncertainty or heart beat perception) on treatment outcome and quality of life in patients with cardiac arrythmias.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04474418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrhythmia
Currently open trials in the same condition.
- NCT06870175 — Smart Textile ECG Monitoring · NA · recruiting
- NCT07205367 — Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II · NA · active not recruiting
- NCT06490432 — Pattern of Cardiac Arrhythmia in Patients With MASLD · recruiting
- NCT06096246 — Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) · NA · recruiting
- NCT06696170 — CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation · NA · recruiting
Other Charite University, Berlin, Germany trials
Trials by the same sponsor.
- NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
- NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
- NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
- NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
- NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04474418 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
- Last refreshed: 16 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing